Business Standard

Thursday, December 19, 2024 | 08:08 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pharma shares trade firm in the weak market; Cipla, Lupin gain over 2%

Pharma stocks got a new lease of life as coronavirus pandemic got a tighter grip on the country in April.

pharmaceutical, pharma, testing, research, doctors, health, drugs, medicine, labaratory
Premium

Among individual stocks, Alembic Pharmaceuticals was up 4 per cent to Rs 775 in the intra-day trade.

SI Reporter Mumbai
Shares of pharmaceutical companies were back in action on Monday with Nifty Pharma index gaining over 1 per cent on the National Stock Exchange (NSE) in an otherwise weak market, after falling 3 per cent in the past three trading days.

At 11:11 am, Nifty Pharma index, the sole gainer among the sectoral indices, was up 1.2 per cent, as compared to a 4.8 per cent decline in the Nifty 50 index. Cipla, Lupin, Cadila Healthcare, Biocon, Aurobindo Pharma, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries and Dr Reddy’s Laboratories were up in the range of 1.4 per cent to 4

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in